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Abstract
Review Article
IntRoductIon
In the developing countries, cervical cancer is the most 
common cancer in women, with the highest rates in 
sub-Saharan Africa, Latin America, and South and South 
East Asia.[1] Invasive cervical cancer is proceeded by a phase 
of the preinvasive disease that is slow to progress and can 
be detected, treated, and collectively referred to as cervical 
intraepithelial neoplasia (CIN). CIN can be confirmed 
histologically from a biopsy sample and divided into three 
stages (CIN1, 2, and 3).[2]
Aim: Invasive cervical cancer is proceeded by a phase of preinvasive disease that is slow to progress and can be detected, 
treated, and collectively referred to as cervical intraepithelial neoplasia (CIN). Several excisional and ablative treatments for CIN 
have been studied, with loop electrosurgical excision procedure (LEEP) and cryotherapy being the two most commonly utilized. 
The objective of this systematic review and meta‑analysis of randomized controlled trials (RCTs) was to compare the compare 
harms and benefits of LEEP versus cryotherapy in women with CIN.
Methods: Electronic databases were searched from their inception until May 2018. We included all RCTs comparing cryotherapy 
versus LEEP in women with CIN. We included trials evaluating both HIV‑seropositive and HIV‑seronegative women. The primary 
outcome was the persistence of the disease at 6‑month follow‑up. Meta‑analysis was performed using the random‑effects model 
to produce summary treatment effects in terms of relative risk (RR) with 95% confidence interval (CI).
Results: Four trials, including 1035 women with CIN, were identified as relevant and included in the meta‑analysis. Women 
who received LEEP for CIN had a significantly lower persistence at 6‑month follow‑up biopsy (RR: 0.87, 95% CI: 0.76–0.99) 
and significantly lower recurrence at 12‑month follow‑up biopsy (RR: 0.91, 95% CI: 0.84–0.99) compared to those who received 
cryotherapy. No between‑group differences were found in the complications rate, but the analyses were not powered for these 
outcomes.
Conclusions: In women with CIN, treatment with LEEP was associated with a significantly lower risk of persistence disease at 
6 months and recurrence disease at 12 months compared to treatment with cryotherapy.
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It has been estimated that, in 70% of affected women, CIN2–3 
can persist or progress to cervical cancer after 10–20 years.[2-4] 
For this reason, ablation or excisional of the transformation 
zone is typically offered to women with biopsy-proven 
CIN. Progression from CIN to cervical cancer is faster, 
and associated mortality is significantly higher, among 
HIV-seropositive compared to HIV-seronegative women.[5-7]
Several excisional and ablative treatments for CIN have 
been studied, including loop electrosurgical excision 
procedure (LEEP), cryotherapy, laser vaporization, cold knife 
conization, and hysterectomy. LEEP and cryotherapy are the 
two most commonly utilized.[3,8-10]
Thus, the aim of this systematic review and meta-analysis 
of randomized controlled trials (RCTs) was to compare the 
compare of LEEP versus cryotherapy in women with CIN.
Methods
Search strategy and selection criteria
This review was performed according to a protocol designed 
a priori and recommended for systematic review.[11] 
Electronic databases (i.e., MEDLINE, PROSPERO, Scopus, 
ClinicalTrials.gov, EMBASE, ScienceDirect, the Cochrane 
Library, Scielo) were searched from their inception until 
May 2018. Search terms used were the following text 
words: “LEEP,” “cryotherapy,” “cervical cancer,” “CIN,” 
“intraepithelial neoplasia,” “electrosurgical excision,” 
“Pap test,” “meta-analysis,” “meta-analysis,” “review,” 
“randomized,” “clinical trial,” “randomized,” and “clinical 
trial.” No restrictions for language or geographic location 
were applied. In addition, the reference lists of all identified 
articles were examined to identify studies not captured 
by electronic searches. The electronic search and the 
eligibility of the studies were independently assessed by 
two authors (MB and GS). Differences were discussed, and 
consensus reached.
We included all RCTs comparing cryotherapy versus LEEP 
in women with CIN. We included trials evaluating both 
HIV-seropositive and HIV-seronegative women. Any grade of 
CIN (CIN1, CIN2, or CIN3) was included. CIN was defined 
as biopsy-proven squamous intraepithelial lesions (SILs).
Quasi-randomized trials (i.e., trials in which allocation was 
done on the basis of a pseudorandom sequence, for example, 
odd/even hospital number or date of birth, alternation) 
were excluded. Trials evaluating other therapies other than 
cryotherapy and LEEP were also excluded.
Data extraction and risk of bias assessment
The risk of bias in each included study was assessed using the 
criteria outlined in the Cochrane Handbook for Systematic 
Reviews of Interventions. Seven domains related to risk 
of bias were assessed in each included trial since there is 
evidence that these issues are associated with biased estimates 
of treatment effect: (1) random sequence generation, 
(2) allocation concealment, (3) blinding of participants and 
personnel, (4) blinding of outcome assessment, (5) incomplete 
outcome data, (6) selective reporting, and (7) other bias. 
Review authors’ judgments were categorized as “low risk,” 
“high risk,” or “unclear risk” of bias.[11]
Two authors (MB and GS) independently assessed inclusion 
criteria, the risk of bias, and data extraction. Disagreements 
were resolved by discussion. Data from each eligible study 
were extracted without modification of original data onto 
custom-made data collection forms. Differences were reviewed 
and further resolved by common review of the entire process. 
Data not presented in the original publications were requested 
from the principal investigators, if possible.
All analyses were done using an intention-to-treat approach, 
evaluating women according to the treatment group to 
which they were randomly allocated in the original trials. 
Primary and secondary outcomes were defined before 
data extraction. Outcomes were assessed at the time of 
biopsy follow-up at 6 months and at 12 months after the 
procedure. If women did not receive for any reason (e.g., 
lost to follow-up, pregnancy) biopsy at follow-up, they were 
excluded from the analysis. All authors were contacted for 
missing data.
The primary outcome was the persistence of the disease, 
defined as disease (any grade of CIN) present at 6-month 
follow-up after treatment. The secondary outcomes were 
recurrence, defined as disease (any grade of CIN) present at 
12 months after treatment and treatment complications.
Statistical analysis
The data analysis was completed independently by two 
authors (MB and GS) using Review Manager version 5.3 (the 
Nordic Cochrane Centre, Cochrane Collaboration, 2014, 
Copenhagen, Denmark). The completed analyses were then 
compared, and any difference was resolved by discussion. 
Statistical heterogeneity across studies was assessed using 
the Higgins I2 test. Meta-analysis was performed using the 
random-effects model of DerSimonian and Laird to produce 
summary treatment effects in terms of relative risk (RR) with 
95% confidence interval (CI).
Potential publication biases were assessed statistically using 
Begg’s and Egger’s tests.
P < 0.05 was considered statistically significant.
We planned the following subgroup analyses for the primary 
endpoint: (1) HIV-seropositive versus HIV-seronegative 
women and (2) trials on CIN2 and CIN3 only.
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The meta-analysis was reported following the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses 
statement.
Results
Study selection and population characteristics
Four trials, including 1035 women, were identified as relevant 
and included in the meta-analysis [Figure 1].[12-15] Data from one 
trial[13] were also obtained by a secondary analysis published 
only as abstract.[16] Publication bias, assessed statistically using 
Begg’s and Egger’s tests, showed no significant bias (P = 0.47 
and P = 0.51, respectively). Statistically, heterogeneity within 
the trials was low with no inconsistency (I2 = 0%) for the 
primary outcome.
The quality of the RCTs included in our meta-analysis was 
assessed using the criteria outlined in the Cochrane Handbook 
for Systematic Reviews of Interventions.[11] Most trials were at 
low or moderate risk of bias. All the included studies had a low 
risk of bias in “random sequence generation.” The appropriate 
method of sequence generation was used to assigned women 
to the treatment groups. Adequate methods for allocation 
of women were used in all the trials. None of the trials 
reported whether or not the outcome assessor was blinded, 
except for the trial of Chirenje et al. where the investigators 
collecting and analyzing the data were blinded to the treatment 
mode [Figure 2a and b].
Table 1 shows the characteristics of the included clinical trials. 
Of the 1035 enrolled women, 516 women were randomized 
in the LEEP group and 519 in the cryotherapy group.
LEEP was usually described as the following: staining the cervix 
with acetic acid solution; abnormal areas were identified and 
stained with Lugol’s iodine; and local anesthetic was administered 
around the cervix. 20 mm × 8 mm loop was used to remove the 
lesion. Cryotherapy was usually described as the following: 
lesions were identified by colposcopy, freezing the lesions for two 
3-min application of nitrous oxide separated by thaw [Table 2].
Mitchell et al. and Singh et al. included women with CIN1+, 
while Chirenje et al. and Smith et al. included only women 
with CIN2+ [Table 1]. Overall, a total of 200 women with 
CIN1 and a total of 835 women with CIN2–3 were included 
in the study [Table 3].
Synthesis of results
Table 4 shows the primary and secondary outcomes. 
Overall, 94.9% of the women (982/1035) had histological 
biopsy results at the 6-month follow-up visit, and data were 
available for the primary endpoint. Pregnancy was the most 
common cause of loss to follow-up. About 72.9% of the 
randomized women (755/1035) had histological biopsy results 
at the 12-month follow-up. Women who received LEEP 
for CIN had a significantly lower persistence at 6-month 
follow-up biopsy (RR: 0.87, 95% CI: 0.76–0.99) [Figure 3] 
and significantly lower recurrence at 12-month follow-up 
biopsy (RR: 0.91, 95% CI: 0.84–0.99) compared to those who 
received cryotherapy. No between-group differences were 
found in the complications rate, but the analyses were not 
powered for these outcomes. LEEP was also associated with 
significantly lower risk of high-grade SIL (HSIL) at 6-month 
Pap smear follow-up (RR: 0.45, 95% CI: 0.28–0.75) and at 
12-month (RR: 0.41, 95% CI: 0.26–0.65) Pap smear follow-up 
compared to cryotherapy [Table 4].
Figure 1: Flow diagram of studies identified in the systematic 
review (Preferred Repor ting Items for Systematic Reviews and 
Meta‑Analyses template)
D’Alessandro, et al.: LEEP vs. cryotherapy for CIN
148 Gynecology and Minimally Invasive Therapy ¦ October-December 2018 ¦ Volume 7 ¦ Issue 4
Table 1: Characteristics of the included studies
Study 
location
Number of 
participants*
Inclusion 
criteria
HIV status Exclusion criteria
Mitchell et al., 1998[12] USA 269 (130 vs. 139) CIN1+ HIV-seropositive and 
HIV-seronegative
Prior treatment for high-grade cytology; 
invasive cervical cancer
Chirenje et al., 2001[13] Zimbabwe 400 (200 vs. 200) CIN2+ HIV-seropositive and 
HIV-seronegative
Prior treatment for high-grade cytology; 
invasive cervical cancer
Singh et al., 2011[14] India 200 (100 vs. 100) CIN1+ HIV-seropositive and 
HIV-seronegative
Prior treatment for high-grade cytology; 
invasive cervical cancer
Smith et al., 2017[15] South Africa 166 (86 vs. 80) CIN2+ HIV-seropositive only Prior treatment for high-grade cytology; 
invasive cervical cancer; cervical lesions 
not appropriate for cryotherapy (>75% of 
the cervix or lesion within the cervical canal 
with borders not visible)
*Data are presented as total number (number in the LEEP group vs. number in the cryotherapy group). HIV: Human immunodeficiency virus, CIN: Cervical 
intraepithelial neoplasia, LEEP: Loop electrosurgical excision procedure
Figure 2: Assessment of risk of bias. (a) Summary of risk of bias for each trial; plus sign: low risk of bias; minus sign: high risk of bias; question mark: 
unclear risk of bias. (b) Risk of bias graph about each risk of bias item presented as percentages across all included studies
ba
Table 2: Details of procedures
LEEP Cryotherapy
Mitchell et al., 1998[12] Staining the cervix with acetic acid solution. Abnormal 
areas were identified and stained with Lugol’s iodine. Local 
anesthetic was administered around the cervix. 20 mm × 8 mm 
loop was used to remove the lesion and the transformation zone 
in one pice if the cervix was 4 cm or smaller. If the cervix was 
larger than 4 cm, the tissue was removed in two section
Lesions identified by colposcopy. Freezing the lesions for 
two 3 min application of nitrous oxide separated by thaw
Mitchell et al., 1998[12] Staining the cervix with 4% acetic acid solution
Local anesthetic was administered around the cervix. 2 cm 
× 2 cm electrode was used for large lesions and 1 cm × 1 1 cm 
for smaller lesions. A few of the large lesions were removed in 
two sections
Lesions identified by colposcopy. Freezing the lesions for 
two 2 min application of nitrous oxide separated by thaw
Singh et al, 2011[14] leep was done under short general anesthesia Freezing the lesions for two 3 min application of nitrous 
oxide separated by 5 min of thawing
Smith et al., 2017[15] Electrosurgical unit with smoke evacuation system. Staining 
the cervix with 5% acetic acid solution. Abnormal areas were 
identified and stained with Lugol’s iodine. Local anesthetic 
was administered around the cervix. The selection of a loop 
electrode was made depending on the size of lesion. A few of 
the large lesions were removed in two sections
VIA conducted by applying 5% acetic acid solution. 
Freezing the lesions for two 3 min application of nitrous 
oxide separated by 5 min of thawing
LEEP: Loop electrosurgical excision procedure, VIA: Visual inspection with acetic acid 
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Table 3: Characteristics of the included women
CIN1, n (%) CIN2, n (%) CIN3, n (%) HPV DNA 
positive, n (%)
Pap smear 
negative, n (%)
LSIL, n (%) HSIL, n (%)
Mitchell 
et al., 1998[12]
40/130 (30.8) 
versus 
42/139 (30.2)
43/130 (33.0) 
versus 
50/139 (36.0)
47/130 (36.2) 
versus 
47/139 (33.8)
70/130 (53.8) 
versus 
76/139 (54.7)
Not reported Not reported Not reported
Mitchell 
et al., 1998[12]
Not reported Not reported Not reported Not reported 0/200 (0) versus 
0/200 (0)
0/200 (0) 
versus 
0/200 (0)
200/200 (100) 
versus 
200/200 (100)
Singh et al., 
2011[14]
55/100 (55.0) 
versus 
63/100 (63.0)
37/100 (37.0) 
versus 
32/100 (32.0)
8/100 (8.0) 
versus 
5/100 (5.0)
Not reported Not reported Not reported Not reported
Smith et al, 
2017[15]
Not reported 60/86 (69.9) 
versus 
56/80 (70.0)
26/86 (69.2) 
versus 
24/80 (30.0)
74/86 (86.0) 
versus 
70/80 (87.5)
2/86 (2.3) versus 
2/80 (2.5)
20/86 (23.3) 
Versus 
18/80 (22.5)
64/86 (74.4) 
versus 
60/80 (75.0)
Total 95/230 (41.3) 
versus 
105/239 (43.9)
140/316 (44.3) 
versus 
138/315 (43.8)
81/316 (25.6) 
versus 
76/319 (24.1)
144/216 (66.7) 
versus 
146/219 (66.7)
2/286 (0.7) 
versus 
2/280 (0.7)
20/286 (7.0) 
versus 
18/280 (6.4)
264/286 (92.3) 
versus 
260/280 (92.9)
Data are presented as n (%) in the LEEP group versus n (%) in the cryotherapy group. CIN: Cervical intraepithelial neoplasia, LEEP: Loop electrosurgical 
excision procedure, LSIL: Low-grade squamous intraepithelial lesion, HSIL: High-grade squamous intraepithelial lesion, HPV: Human papillomavirus
Figure 3: Forest plot for the risk of persistence of the disease, defined as any grade of cervical intraepithelial neoplasia at the biopsy 6 months after 
the procedure
Subgroup analysis in trials including only women with CIN2 + and 
subgroup analysis in trials including HIV-positive only women 
concurred with the overall analysis in showing significant benefit 
of LEEP for the primary endpoint (RR: 0.89, 95% CI: 0.77–0.98 
and RR: 0.88, 95% CI: 0.76–0.99, respectively).
dIscussIon
Main findings
This meta-analysis of four RCTs, including 1035 women with 
CIN, showed that treatment with LEEP was associated with 
a significantly lower risk of persistence disease at 6 months 
and recurrence disease at 12 months compared to treatment 
with cryotherapy. The meta-analysis also showed a significant 
reduction of HSIL at 6-month and at 12-month Pap smear 
follow-up and nonsignificant benefits in the other secondary 
outcomes, including CIN3 at 6 and 12-month follow-up biopsy. 
No between-group differences were found in the complications 
rate comparing the two treatments with a nonsignificant increase 
in pain, infection, and bleeding in women receiving LEEP. 
However, the meta-analysis was not powered for these outcomes.
Strengths and limitations
This may be the first meta-analysis of RCTs comparing LEEP 
with cryotherapy in women with CIN. No prior meta-analyses are 
up to date and comprehensive in terms of included studies, and the 
number of women included in our analysis is the highest among 
all review available. Potential publication bias was assessed by 
statistical tests, and statistics suggested no publication bias. The 
statistical heterogeneity within the trial was low for the primary 
endpoint. Overall, >90% of the women had histological biopsy 
results at the 6-month follow-up visit for the primary endpoint.
The major shortcoming of this review was the inclusion of 
only four trials. Given the intervention, none of the included 
trials were double blind. The meta-analysis was underpowered 
to detect significant differences in the complications rate.
Implications
The American College of Obstetricians and Gynecologists and 
the American Society for Colposcopy and Cervical Pathology 
in the 2012 ASCCP Consensus Guidelines Conference 
recommended colposcopy for women with HSIL cytology.[17] In 
the case of colposcopy and biopsy, women with CIN should be 
managed with either excision or ablation. Therefore, both LEEP 
and cryotherapy are reasonable and recommended treatment 
for women with CIN.[17] No specific recommendations are 
made in HIV-positive women. HIV-positive women have an 
increased risk of cervical cancer, as well as an increased risk 
of procedure-related complications.[18]
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In LEEP, a wire electrical loop removes the abnormal cervical 
lesion within a clinical setting. Cryotherapy treatment 
is the local destruction of cervical tissue by application 
of subfreezing temperatures causing crystallization and 
rupture of cell membranes. Cryotherapy has the limitation 
that approximately 25% of CIN2+ lesions cannot be treated 
adequately (those that cover >75% of the cervix or extend 
into the cervical canal).[9,10,19]
Our review provided evidence that LEEP treatment is superior 
in terms of less persistence and less recurrence rate at 6 and 
12-month follow-up visit compared to cryotherapy. Our study 
concurred with prior findings of Santesso et al.[20]
conclusIons
In summary, in women with CIN, treatment with LEEP was 
associated with a significantly lower risk of persistence 
disease at 6 months and recurrence disease at 12 months 
compared to treatment with cryotherapy.
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